advertisement

WGW-2021

11.15 Other drugs in relation to glaucoma (1571)

Showing records 1 to 25

Display only abstracts from IGR 20-4 in classification 11.15 Other drugs in relation to glaucoma

Search within classification 11.15 Other drugs in relation to glaucoma

84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Zhang F
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


85216 Challenging Management of Neovascular Glaucoma to Achieve the Best Visual Outcome
Putera I
Case Reports in Ophthalmology 2020; 11: 85-91 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Yu J
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Elgin U
International Ophthalmology 2019; 0: (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Lommatzsch C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
McKay KM
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Bilgic A
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Du J
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84841 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
Chen YY
BMC Ophthalmology 2019; 19: 268 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Wingard JB
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84623 The role of intracranial pressure in glaucoma and therapeutic implications
Baneke AJ
Eye 2020; 34: 178-191 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Monsellato R
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Bilgic A
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


84409 Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes
Patrie JT
Journal of Glaucoma 2019; 28: 1035-1040 (IGR: 21-1)


84241 Effects of rosiglitazone/PHBV drug delivery system on postoperative fibrosis in rabbit glaucoma filtration surgery model
Liu K
Drug Delivery 2019; 26: 812-819 (IGR: 21-1)


85122 Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab
Kodjikian L
Journal of Ophthalmology 2020; 2020: 7462098 (IGR: 21-1)


84868 Comparison of Modified Posterior Sub-Tenon's vs. Trans-Septal Triamcinolone Injection for Non-infectious Uveitis
Borkar DS
Ocular Immunology and Inflammation 2020; 0: 1-8 (IGR: 21-1)


84904 Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Delzell DA
Clinical Ophthalmology 2019; 13: 2563-2572 (IGR: 21-1)


84776 Ocular hypertension management in long-term treatments with intravitreal dexamethasone implants: a 3-year experience
Trovato E
Clinica Terapeutica 2020; 170: e11-e14 (IGR: 21-1)


84576 Modified Cortex Mori Capsules improving the successful rate of functional filtering blebs after reclinical glaucoma filtering surgery
Qiu LX
World journal of clinical cases 2019; 7: 3436-3445 (IGR: 21-1)


84661 The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis
Sen E
International Ophthalmology 2019; 0: (IGR: 21-1)


84623 The role of intracranial pressure in glaucoma and therapeutic implications
Aubry J
Eye 2020; 34: 178-191 (IGR: 21-1)


85137 Bevacizumab as an Adjunct to Trabeculectomy in Primary Open-Angle Glaucoma: A Randomized Trial
Sudhalkar A
Journal of Ophthalmology 2020; 2020: 8359398 (IGR: 21-1)


84088 Trabeculectomy with Collagen Matrix Implant as Bevacizumab Depot: Clinical Results on Efficacy and Safety
Heinz C
Klinische Monatsblätter für Augenheilkunde 2020; 237: 62-70 (IGR: 21-1)


85216 Challenging Management of Neovascular Glaucoma to Achieve the Best Visual Outcome
Suryono AN
Case Reports in Ophthalmology 2020; 11: 85-91 (IGR: 21-1)



Issue 20-4

Select Issue


advertisement

Oculus